GO:0035250 UDP-galactosyltransferase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0035250 (UDP-galactosyltransferase activity) is a molecular function defined as the catalysis of galactose transfer from UDP-galactose to an acceptor molecule.
• This activity is central to glycoconjugate biosynthesis, including flavonol glycosylation in plants and gastric mucosal glycosylation in mammals [1,2,3].
• Enzymes with this activity belong to the UDP-glycosyltransferase superfamily and often exhibit acceptor promiscuity, enabling diverse glycoconjugate products [1,6].
• Altered UDP-galactosyltransferase activity has been observed in chronic liver disease and after exposure to gastroprotective agents, suggesting clinical relevance [2,5].
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models are essential to dissect the causal roles of specific UDP-galactosyltransferase genes.
• EDITGENE provides end-to-end services for functional validation of UDP-galactosyltransferase genes, from cell line engineering to CRISPR library screening and bioinformatics.
Description
UDP-galactosyltransferase activity (GO:0035250) is a molecular function that catalyzes the transfer of a galactose group from UDP-galactose to an acceptor molecule. This activity is fundamental to the biosynthesis of glycoproteins, glycolipids, and other glycoconjugates, and it is widely distributed across prokaryotes, plants, and animals. In plants, UDP-galactosyltransferases participate in the glycosylation of flavonoids, influencing their solubility, stability, and bioactivity. In mammals, the activity has been detected in gastric mucosa and other tissues, where it contributes to mucosal defense and glycocalyx maintenance [2,3]. The clinical importance of this activity is underscored by its alteration in chronic liver disease and its modulation by gastroprotective agents [2,5]. Researchers study UDP-galactosyltransferase activity to understand glycobiology, develop therapeutic strategies, and engineer glycosylation pathways in industrial organisms [6,7]. The availability of CRISPR-based models now allows precise interrogation of individual genes encoding this activity, accelerating both basic and translational research.
UDP-galactosyltransferase activity At A Glance
| GO ID | GO:0035250 |
|---|---|
| GO term | UDP-galactosyltransferase activity |
| Ontology | molecular_function |
| Synonym | none |
| Major function | Transfer of galactose from UDP-galactose to an acceptor molecule |
| EC number | 2.4.1.- (glycosyltransferases) |
| Substrates | UDP-galactose (donor); various acceptors (e.g., flavonoids, proteins, lipids) |
| Cellular localization | Golgi apparatus, cytoplasm, and other compartments depending on the enzyme |
| Representative genes | UGT genes in plants; B3GALT, GALNT, and other families in mammals |
What Is GO:0035250?
According to the Gene Ontology, GO:0035250 (UDP-galactosyltransferase activity) is defined as the catalysis of the transfer of a galactose group from UDP-galactose to an acceptor molecule. This activity typically involves the recognition of UDP-galactose as the donor substrate and a diverse range of acceptors, including proteins, lipids, and small molecules such as flavonoids. The reaction proceeds via a glycosyl transfer mechanism, often with inversion or retention of anomeric configuration, and is essential for the biosynthesis of galactose-containing glycoconjugates.
Why Is UDP-galactosyltransferase activity Important in Cell Biology?
UDP-galactosyltransferase activity is essential for the synthesis of galactose-containing glycoconjugates, which play critical roles in cell-cell recognition, signaling, and structural integrity. Dysregulation of this activity has been linked to gastric mucosal injury, chronic liver disease, and cancer progression [2,5]. In biotechnology, plant UDP-galactosyltransferases are exploited to produce glycosylated flavonoids with improved pharmacological properties [1,6]. Understanding the molecular mechanisms and regulation of this activity is therefore vital for both biomedical research and industrial applications.
• Required for the biosynthesis of glycoproteins and glycolipids, impacting cell signaling and adhesion.
• Modulates flavonoid glycosylation in plants, affecting antioxidant and pharmacological activities.
• Altered activity in chronic liver disease suggests a role in hepatic dysfunction.
• Increased activity in gastric mucosa after treatment with geranylgeranylacetone and cetraxate hydrochloride indicates involvement in mucosal protection.
• Enables glycoengineering of recombinant proteins in CHO cells for improved therapeutic properties.
• Contributes to lysosomal membrane integrity in retinal pigment epithelial cells.
• Potential target for anti-inflammatory and gastroprotective drugs.
• Key enzyme for the production of glycosylated natural products in agricultural and pharmaceutical industries.
Molecular Mechanism of UDP-galactosyltransferase activity
Substrate recognition and binding
In simple terms: The enzyme grabs UDP-galactose and holds it in place to transfer the sugar.
UDP-galactosyltransferases specifically bind UDP-galactose as the donor substrate and a diverse acceptor molecule. The binding site recognizes the UDP moiety and the galactose ring, ensuring high fidelity. In plant enzymes such as those from Morella rubra, the acceptor can be a flavonol, and the enzyme exhibits regioselectivity. In mammals, acceptors include glycoproteins and glycolipids, with enzymes like B3GALT and GALNT families showing distinct acceptor specificities.
Catalytic transfer of galactose
In simple terms: The enzyme snips off galactose from UDP and attaches it to the acceptor.
The catalytic mechanism involves the cleavage of the glycosidic bond between UDP and galactose, followed by the transfer of the galactose moiety to the acceptor. This reaction often proceeds via a concerted mechanism with an oxocarbenium ion-like transition state. The enzyme may use a divalent metal ion cofactor, typically Mn2+, to stabilize the leaving group and facilitate catalysis. The anomeric configuration of the product can be either inverted or retained relative to the donor, depending on the enzyme family.
Cofactors and metal ion dependence
In simple terms: Many of these enzymes need a metal helper to work properly.
Many UDP-galactosyltransferases require divalent metal ions such as Mn2+ or Mg2+ for activity. These ions coordinate with the UDP moiety and the enzyme's active site residues, stabilizing the transition state. However, some enzymes, particularly plant UDP-glycosyltransferases, are metal-independent. The metal dependence can be exploited for purification and assay development.
Regulation of enzyme activity
In simple terms: The cell can dial up or down the activity of these enzymes.
UDP-galactosyltransferase activity is regulated at multiple levels, including transcriptional control, post-translational modifications, and substrate availability. In rat gastric mucosa, activity is increased by geranylgeranylacetone and cetraxate hydrochloride, suggesting pharmacological modulation. In CHO cells, galactose feeding alters the expression of glycosylation genes, including galactosyltransferases, to optimize recombinant protein production. Additionally, the activity can be influenced by the cellular redox state and by interactions with other glycosyltransferases.
Key Genes Involved in GO:0035250 UDP-galactosyltransferase activity
The following genes encode enzymes with UDP-galactosyltransferase activity or are directly involved in its regulation and application.
| Gene | Major Role | Research Relevance |
|---|---|---|
| UGT (plant) | Flavonol glycosylation | Enables production of glycosylated flavonoids with enhanced bioactivity |
| GmSGT2 | Galactosylation of glycyrrhetinic acid derivatives | Biocatalytic production of glycosylated triterpenoids |
| B3GALT | Beta-1,3-galactosyltransferase | Glycoprotein and glycolipid synthesis; cancer biomarkers |
| GALNT | Polypeptide N-acetylgalactosaminyltransferase | O-glycosylation initiation; not directly galactosyltransferase but related |
| UGT8 | Galactosylceramide synthase | Synthesis of galactolipids in myelin and neurons |
| A4GALT | Alpha-1,4-galactosyltransferase | Globotriaosylceramide synthesis; Fabry disease |
| B4GALT | Beta-1,4-galactosyltransferase | Lactose synthesis; glycoprotein processing |
| UGT1A | UDP-glucuronosyltransferase | Not galactosyltransferase but shares UDP-sugar donor |
| CSGALNACT | Chondroitin sulfate N-acetylgalactosaminyltransferase | Proteoglycan synthesis |
| EXTL | Exostosin-like glycosyltransferase | Heparan sulfate biosynthesis |
| POMGNT | Protein O-mannose beta-1,2-N-acetylglucosaminyltransferase | O-mannosyl glycosylation; muscular dystrophy |
| LARGE1 | Glycosyltransferase-like protein | Alpha-dystroglycan glycosylation; muscular dystrophy |
| FUT | Fucosyltransferase | Not galactosyltransferase but competing glycosylation |
| ST3GAL | Sialyltransferase | Sialylation; not galactosyltransferase but related |
| CHPF | Chondroitin polymerizing factor | Chondroitin sulfate synthesis |
| CSGALNACT1 | Chondroitin sulfate N-acetylgalactosaminyltransferase 1 | Cartilage and brain development |
How Is UDP-galactosyltransferase activity Regulated?
UDP-galactosyltransferase activity is regulated by substrate availability, enzyme expression levels, and post-translational modifications. In rat gastric mucosa, activity is stimulated by geranylgeranylacetone and cetraxate hydrochloride, indicating pharmacological upregulation. In CHO cells, galactose feeding modulates the expression of glycosylation genes, including galactosyltransferases, to enhance recombinant glycoprotein production. Additionally, the activity can be influenced by the cellular redox state and by interactions with other glycosyltransferases. Hormonal and metabolic signals may also affect activity, as seen in chronic liver disease where activity is altered.
UDP-galactosyltransferase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| B3GALT | Cancer, glycosylation abnormalities | Knockout in cancer cell lines |
| A4GALT | Fabry disease | Point mutation knock-in in iPSCs |
| UGT8 | Multiple sclerosis, myelin disorders | Overexpression in oligodendrocytes |
| GALNT | Cancer, O-glycosylation defects | CRISPR knockout in HEK293 |
| LARGE1 | Muscular dystrophy | Knock-in of patient mutations in myoblasts |
Chronic liver disease
UDP-galactosyltransferase activity in gastric mucosa is altered in patients with chronic liver disease, as assessed by an enzyme-linked peanut agglutinin binding assay. This suggests that hepatic dysfunction may impact glycosylation processes in the gastrointestinal tract, potentially contributing to mucosal vulnerability.
Gastric mucosal injury and protection
Geranylgeranylacetone and cetraxate hydrochloride increase UDP-galactosyltransferase activity in rat gastric mucosa, indicating a role in mucosal defense and repair. Analysis of galactosyltransferase activity in crude mucosal homogenates provides a basis for understanding these protective mechanisms.
Lysosomal membrane integrity in retinal pigment epithelium
Isolation of intact lysosomes from human RPE cells and studies with A2-E, a lipofuscin component, suggest that lysosomal membrane integrity is influenced by glycosylation processes, including galactosyltransferase activity. This has implications for age-related macular degeneration.
From UDP-galactosyltransferase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of B3GALT affect cell surface glycosylation? | CRISPR knockout in HeLa or HEK293 cells |
| Does a specific point mutation in A4GALT alter enzyme activity? | Point mutation knock-in in iPSCs |
| Can overexpression of UGT8 enhance galactolipid synthesis? | Overexpression in CHO or Neuro2a cells |
| What is the interactome of a tagged galactosyltransferase? | Tagged knock-in (e.g., FLAG, HA) in HeLa cells |
| Which genes regulate UDP-galactosyltransferase activity? | CRISPR library screening in a reporter cell line |
| Does galactose feeding alter glycosylation gene expression? | RNA-seq of CHO cells overexpressing IL-4/13 cytokine trap |
How to Study the UDP-galactosyltransferase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radiolabeled UDP-galactose assay | Enzyme activity | Kinetic studies of purified enzymes |
| Lectin binding assay | Galactose-containing glycoconjugates | Clinical samples, mucosal homogenates |
| Mass spectrometry glycomics | Glycan structures | Characterization of products |
| RNA-seq | Gene expression | Transcriptional regulation |
| CRISPR knockout | Gene function | Loss-of-function studies |
| CRISPR point mutation | Specific amino acid function | Structure-function analysis |
| CRISPR knock-in | Tagged protein localization | Imaging and interactomics |
| Overexpression | Gain-of-function | Biocatalysis and pathway engineering |
Enzymatic activity assays
UDP-galactosyltransferase activity can be measured using radiolabeled UDP-[3H]galactose or fluorescently labeled acceptors. In gastric mucosa, activity was assessed using an enzyme-linked peanut agglutinin binding assay. Crude mucosal homogenates have also been used to analyze galactosyltransferase activity. These assays are essential for validating enzyme function and screening inhibitors.
Glycan profiling and lectin binding
Lectin-based assays, such as peanut agglutinin binding, can detect galactose-containing glycoconjugates. This approach was used to assess UDP-galactosyltransferase activity in chronic liver disease. Mass spectrometry-based glycomics provides detailed structural information on glycans produced by these enzymes.
Gene expression analysis
RNA-seq and qPCR can quantify the expression of genes encoding UDP-galactosyltransferases. In CHO cells, gene-expression profiles for five key glycosylation genes were analyzed under galactose feeding. This method helps identify transcriptional regulation of the activity.
CRISPR-based functional genomics
CRISPR knockout, point mutation, and overexpression models enable causal interrogation of specific genes. For example, knockout of B3GALT can reveal its role in cell surface glycosylation. CRISPR library screening can identify genes that regulate UDP-galactosyltransferase activity in a high-throughput manner.
How CRISPR Can Be Used to Study GO:0035250 UDP-galactosyltransferase activity
Knockout
CRISPR knockout of genes encoding UDP-galactosyltransferases (e.g., B3GALT, A4GALT) can abolish enzyme activity, leading to loss of specific glycoconjugates. This is useful to determine the physiological role of each enzyme and to create cell models for disease research.
Point Mutation
Introducing point mutations in the catalytic domain of a UDP-galactosyltransferase can reveal critical residues for substrate binding and catalysis. For example, mutating the DXD motif in glycosyltransferases often abolishes activity. Such models help validate enzyme mechanisms and identify pathogenic variants.
Knock-in
Knock-in of a tag (e.g., FLAG, GFP) into the endogenous locus allows visualization and immunoprecipitation of the enzyme at physiological expression levels. This is valuable for studying subcellular localization and protein interactions.
Overexpression
Overexpression of a UDP-galactosyltransferase gene can enhance the production of specific glycoconjugates, which is useful for biocatalysis and for studying gain-of-function phenotypes. In CHO cells, overexpression of glycosylation genes improves recombinant protein quality.
How EDITGENE Supports UDP-galactosyltransferase activity Research
Researchers studying UDP-galactosyltransferase activity-related genes often need to determine whether a candidate gene is causally involved in a specific glycosylation pathway or disease phenotype. EDITGENE provides a comprehensive suite of CRISPR services to enable such functional validation, from single-gene knockout to high-throughput library screening.
Contact EDITGENE today to design your custom CRISPR model for UDP-galactosyltransferase activity research.
Frequently Asked Questions About UDP-galactosyltransferase activity
What is UDP-galactosyltransferase activity?
UDP-galactosyltransferase activity (GO:0035250) is a molecular function that catalyzes the transfer of a galactose group from UDP-galactose to an acceptor molecule, forming galactose-containing glycoconjugates.
What genes are involved in UDP-galactosyltransferase activity?
Genes encoding this activity include plant UGTs, GmSGT2, and mammalian B3GALT, A4GALT, B4GALT, and UGT8 families, among others [1,6].
How is UDP-galactosyltransferase activity measured?
It can be measured using radiolabeled UDP-galactose assays, lectin binding assays (e.g., peanut agglutinin), or mass spectrometry-based glycomics.
What diseases are associated with altered UDP-galactosyltransferase activity?
Altered activity has been observed in chronic liver disease, gastric mucosal injury, and lysosomal storage disorders such as Fabry disease [2,5,8].
Can CRISPR be used to study UDP-galactosyltransferase activity?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models allow precise functional interrogation of genes encoding this activity.
What is the role of UDP-galactosyltransferase in plants?
In plants, it participates in flavonol glycosylation, affecting the solubility and bioactivity of flavonoids.
How is UDP-galactosyltransferase activity regulated?
It is regulated by substrate availability, transcriptional control, post-translational modifications, and pharmacological agents such as geranylgeranylacetone.
What is the difference between UDP-galactosyltransferase and UDP-glucosyltransferase?
Both transfer sugars from UDP-sugars, but UDP-galactosyltransferase specifically transfers galactose, while UDP-glucosyltransferase transfers glucose.
Which cell lines are commonly used to study UDP-galactosyltransferase activity?
CHO cells, HEK293, HeLa, and gastric mucosal cells are commonly used, depending on the research question [3,7].
How can I create a knockout of a UDP-galactosyltransferase gene?
EDITGENE provides custom CRISPR knockout services for any gene of interest, with validated clones and functional characterization.
Conclusion
UDP-galactosyltransferase activity (GO:0035250) is a fundamental molecular function with broad biological and clinical significance. From plant flavonoid glycosylation to mammalian gastric mucosal protection and liver disease, this activity impacts diverse physiological and pathological processes [1,2,5]. Advances in CRISPR-based genome editing now enable precise dissection of the genes responsible, offering new opportunities for therapeutic development and biotechnological applications. EDITGENE stands ready to support these efforts with comprehensive cell model engineering and screening services.
References
- 1. Ren C et al.. 2022. Identification of UDP-rhamnosyltransferases and UDP-galactosyltransferase involved in flavonol glycosylation in Morella rubra.. Hortic Res 9:uhac138 PMID: 36072838
- 2. Mikami Y et al.. 1997. Geranylgeranylacetone and cetraxate hydrochloride increase UDP-galactosyltransferase activity in rat gastric mucosa.. Acta Med Okayama 51(5):245-9 PMID: 9359921
- 3. Hongo T et al.. 1991. Analysis of galactosyltransferase activity in rat gastric mucosa using crude mucosal homogenate.. Acta Med Okayama 45(5):301-8 PMID: 1755334
- 5. Maga T et al.. 1997. Assessment of UDP-galactosyl-transferase activity in gastric mucosa of patients with chronic liver disease using an enzyme-linked peanut agglutinin binding assay.. Digestion 58(4):389-95 PMID: 9324168
- 6. Gao Y et al.. 2020. Galactosylation of Monosaccharide Derivatives of Glycyrrhetinic Acid by UDP-Glycosyltransferase GmSGT2 from Glycine max.. J Agric Food Chem 68(32):8580-8588 PMID: 32689796
- 7. Clark KJ et al.. 2005. Gene-expression profiles for five key glycosylation genes for galactose-fed CHO cells expressing recombinant IL-4/13 cytokine trap.. Biotechnol Bioeng 90(5):568-77 PMID: 15818560
- 8. Schütt F et al.. 2002. Isolation of intact lysosomes from human RPE cells and effects of A2-E on the integrity of the lysosomal and other cellular membranes.. Graefes Arch Clin Exp Ophthalmol 240(12):983-8 PMID: 12483320
